Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Liver fibrosis is the scarring process that represents the liver’s response to injury. In the same way as skin and other organs heal wounds through deposition of collagen and other matrix constituents so the liver repairs injury through the deposition of new collagen.
The classification of Liver Fibrosis Drug includes nucleoside, interferon and others, and the proportion of nucleoside type in 2018 is about 45.37%, and the proportion keeps stable trend from 2014 to 2025.Liver fibrosis drug is widely used for Hepatitis, Liver Fibrosis and Other. The most proportion of Interferon is used for hepatitis, and the proportion in 2018 is 68.37%.North America is the largest consumption place, with a consumption market share nearly 47.09% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 25.14%. Market competition is intense. Roche, Gilead, Merck & Co, Merck KGaA, Biogen Idec, Bristol-Myers Squibb Company., Inc and Tri-Prime are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The report details the trend, potential and market size of Liver Fibrosis Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Liver Fibrosis Drugmarket, defines the market attractiveness level of Liver Fibrosis Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Liver Fibrosis Drug industry, describes the types of Liver Fibrosis Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Liver Fibrosis Drug market and the development prospects and opportunities of Liver Fibrosis Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Liver Fibrosis Drug market in Chapter 13.
By Player:
Roche
Gilead
Merck & Co
Merck KGaA
Biogen Idec
Bristol-Myers Squibb Company
Tri-Prime
By Type:
Nucleoside
Interferon
Other
By End-User:
Hepatitis
Liver Fibrosis
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Liver Fibrosis Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Liver Fibrosis Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Liver Fibrosis Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Liver Fibrosis Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Liver Fibrosis Drug Market Analysis and Outlook to 2022
-
7.1 Global Liver Fibrosis Drug Consumption (2017-2022)
-
7.2 United States Liver Fibrosis Drug Consumption (2017-2022)
-
7.3 Europe Liver Fibrosis Drug Consumption (2017-2022)
-
7.4 China Liver Fibrosis Drug Consumption (2017-2022)
-
7.5 Japan Liver Fibrosis Drug Consumption (2017-2022)
-
7.6 India Liver Fibrosis Drug Consumption (2017-2022)
-
7.7 South Korea Liver Fibrosis Drug Consumption (2017-2022)
8 Region and Country-wise Liver Fibrosis Drug Market Analysis and Outlook to 2028
-
8.1 Global Liver Fibrosis Drug Consumption Forecast (2022-2028)
-
8.2 United States Liver Fibrosis Drug Consumption Forecast (2022-2028)
-
8.3 Europe Liver Fibrosis Drug Consumption Forecast (2022-2028)
-
8.4 China Liver Fibrosis Drug Consumption Forecast (2022-2028)
-
8.5 Japan Liver Fibrosis Drug Consumption Forecast (2022-2028)
-
8.6 India Liver Fibrosis Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Liver Fibrosis Drug Consumption Forecast (2022-2028)
9 Global Liver Fibrosis Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Liver Fibrosis Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Nucleoside Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Interferon Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Liver Fibrosis Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hepatitis Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Liver Fibrosis Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Liver Fibrosis Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Liver Fibrosis Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Nucleoside Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Interferon Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Liver Fibrosis Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hepatitis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Liver Fibrosis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Liver Fibrosis Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Liver Fibrosis Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Liver Fibrosis Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Liver Fibrosis Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Liver Fibrosis Drug Market Competitive Analysis
-
14.1 Roche
-
14.1.1 Roche Company Details
-
14.1.2 Roche Liver Fibrosis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Roche Liver Fibrosis Drug Product and Service
-
14.2 Gilead
-
14.2.1 Gilead Company Details
-
14.2.2 Gilead Liver Fibrosis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Gilead Liver Fibrosis Drug Product and Service
-
14.3 Merck & Co
-
14.3.1 Merck & Co Company Details
-
14.3.2 Merck & Co Liver Fibrosis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Merck & Co Liver Fibrosis Drug Product and Service
-
14.4 Merck KGaA
-
14.4.1 Merck KGaA Company Details
-
14.4.2 Merck KGaA Liver Fibrosis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Merck KGaA Liver Fibrosis Drug Product and Service
-
14.5 Biogen Idec
-
14.5.1 Biogen Idec Company Details
-
14.5.2 Biogen Idec Liver Fibrosis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Biogen Idec Liver Fibrosis Drug Product and Service
-
14.6 Bristol-Myers Squibb Company
-
14.6.1 Bristol-Myers Squibb Company Company Details
-
14.6.2 Bristol-Myers Squibb Company Liver Fibrosis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Bristol-Myers Squibb Company Liver Fibrosis Drug Product and Service
-
14.7 Tri-Prime
-
14.7.1 Tri-Prime Company Details
-
14.7.2 Tri-Prime Liver Fibrosis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Tri-Prime Liver Fibrosis Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Liver Fibrosis Drug
-
Figure Liver Fibrosis Drug Picture
-
Table Global Liver Fibrosis Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Liver Fibrosis Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Liver Fibrosis Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Liver Fibrosis Drug Consumption by Country (2017-2022)
-
Figure United States Liver Fibrosis Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Liver Fibrosis Drug Consumption and Growth Rate (2017-2022)
-
Figure China Liver Fibrosis Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Liver Fibrosis Drug Consumption and Growth Rate (2017-2022)
-
Figure India Liver Fibrosis Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Liver Fibrosis Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Liver Fibrosis Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Liver Fibrosis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Liver Fibrosis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Liver Fibrosis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Liver Fibrosis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Liver Fibrosis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Liver Fibrosis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Nucleoside Consumption and Growth Rate (2017-2022)
-
Figure Global Interferon Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Hepatitis Consumption and Growth Rate (2017-2022)
-
Figure Global Liver Fibrosis Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Nucleoside Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Interferon Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hepatitis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Liver Fibrosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Liver Fibrosis Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Liver Fibrosis Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Liver Fibrosis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Liver Fibrosis Drug Product and Service
-
Table Gilead (Foundation Year, Company Profile and etc.)
-
Table Gilead Liver Fibrosis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Liver Fibrosis Drug Product and Service
-
Table Merck & Co (Foundation Year, Company Profile and etc.)
-
Table Merck & Co Liver Fibrosis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co Liver Fibrosis Drug Product and Service
-
Table Merck KGaA (Foundation Year, Company Profile and etc.)
-
Table Merck KGaA Liver Fibrosis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck KGaA Liver Fibrosis Drug Product and Service
-
Table Biogen Idec (Foundation Year, Company Profile and etc.)
-
Table Biogen Idec Liver Fibrosis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Idec Liver Fibrosis Drug Product and Service
-
Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Company Liver Fibrosis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Company Liver Fibrosis Drug Product and Service
-
Table Tri-Prime (Foundation Year, Company Profile and etc.)
-
Table Tri-Prime Liver Fibrosis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tri-Prime Liver Fibrosis Drug Product and Service
-
